Back to All Events
Click here for more information about Federal Notice 86 FR 4088 FDA Proposal to Make Permanent Regulatory Flexibilities Provided During the COVID-19 Public Health Emergency.
Previous
Previous
January 28
Federal Register Session
Next
Next
February 4